Valor202020212022202320242025Total de pasivos35.11 M35.05 M58.57 M38.38 M34.34 M18.04 MCapital total101.97 M169.44 M136.85 M106.02 M97.37 M76.58 MTotal de pasivos y patrimonio neto137.08 M204.49 M195.42 M144.4 M131.71 M94.62 MDeuda total——————Deuda neta——————
Arbutus Biopharma Corporation - Common Stock
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.